Results 271 to 280 of about 7,228,361 (402)

Selection for soybean seed yield with molecular markers

, 1999
J. R. Byrum
openalex   +2 more sources

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

Molecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts, Senada Koljenović, Elise Daems, Karolien De Wael, Marc Peeters, Léon C. van Kempen, Greetje Vanhoutte, Karen Zwaenepoel, Timon Vandamme   +8 more
wiley   +1 more source

Commentary: The Case for Abandoning Therapeutic Chelation of Copper Ions in Alzheimer’s Disease

Frontiers in Neurology, 2017
Rosanna Squitti, Carlo Salustri, Mauro Rongioletti, Mariacristina Siotto   +3 more
doaj   +1 more source

Exploration of Small Non-Coding RNAs as Molecular Markers of Ram Sperm Fertility. [PDF]

Int J Mol Sci
Bodu M, Hitit M, Donmez H, Kaya A, Ugur MR, Memili E.   +5 more
europepmc   +1 more source

Molecular markers: Implications for cytopathology and specimen collection

Cancer Cytopathology, 2015
P. VanderLaan
semanticscholar   +1 more source

Investigating the cell of origin and novel molecular targets in Merkel cell carcinoma: a historic misnomer

Molecular Oncology, EarlyView.
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian, Sriraam Sivachandran, Melissa Galati, Brandon Ramchatesingh, Hibo Rijal, Johnny Hanna, Elena Netchiporouk, May Chergui, Margaret Redpath, Samy Abou Setah, Ivan V. Litvinov   +10 more
wiley   +1 more source

Chemotaxis-related molecular markers underlying the immune disorder of psoriasis and ulcerative colitis: Preliminary analysis and verification. [PDF]

Medicine (Baltimore)
Zhang Q, Qin X, Liang D, Li W, Luo S, Lin Y.   +5 more
europepmc   +1 more source

Molecular Markers: an Introduction and Applications

, 2015
F. Al-Samarai, A. Al-kazaz
semanticscholar   +1 more source

Hypomethylating agents increase L1 retroelement expression without inducing novel insertions in myeloid malignancies

Molecular Oncology, EarlyView.
We investigated whether hypomethylating agents (HMAs) used in myeloid malignancies induce somatic retrotransposition. Our findings indicate that HMA treatment increases L1‐encoded protein expression but does not lead to detectable de novo retrotransposition events in either patient samples or cell lines.
Šárka Pavlová, Hana Svozilová, Marcela Krzyžánková, Radim Sonnek, Anastasiya Volakhava, Anastasia Smirnova, Tatiana Grigoreva, Zuzana Jašková, Hana Synáčková, Dennis Wahl, Michaela Bilčíková, Libor Červinek, Šárka Pospíšilová, Ilgar Mamedov, Karla Plevová   +14 more
wiley   +1 more source

Molecular markers enhance substantially the distinctness of alfalfa varieties for registration and protection. [PDF]

Plant Genome
Annicchiarico P, Franguelli N, Ferrari B, Campanella G, Gualanduzzi S, Crosta M, Delogu C, Spataro G, Nazzicari N.   +8 more
europepmc   +1 more source